What laboratory testing is indicated to evaluate hereditary hemochromatosis in a patient with elevated liver enzymes and elevated iron levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing for Hemochromatosis with Elevated Liver Enzymes and Iron Levels

In a patient with elevated liver enzymes and elevated iron levels, you should immediately measure transferrin saturation and serum ferritin, followed by HFE genetic testing (specifically for C282Y mutation) if transferrin saturation is >45% in females or >50% in males, combined with ferritin >200 μg/L in females or >300 μg/L in males 1, 2.

Initial Biochemical Testing Algorithm

The first step is confirming iron overload with specific parameters 1, 2:

  • Transferrin saturation (TS): Calculate from serum iron divided by total iron-binding capacity

    • Threshold: >45% in women, >50% in men warrants further investigation
    • Confirm elevated TS with a second determination (fasting sample is reasonable but no longer mandatory) 2
  • Serum ferritin:

    • Threshold: >200 μg/L in women, >300 μg/L in men suggests iron overload
    • Critical caveat: Ferritin is an acute phase reactant and can be falsely elevated in necroinflammatory liver disease (alcoholic liver disease, chronic hepatitis B/C, NAFLD), lymphomas, and other inflammatory conditions 2
  • Additional iron parameters (optional but helpful for differential diagnosis):

    • Serum iron concentration
    • Total iron-binding capacity or transferrin level 1

Genetic Testing Criteria

Proceed to HFE genotyping when 1:

  • Transferrin saturation >45% (females) or >50% (males) AND
  • Ferritin >200 μg/L (females) or >300 μg/L (males) OR
  • Persistently elevated transferrin saturation even with normal ferritin

Specific genetic testing approach 1:

  • Test for p.C282Y mutation in HFE gene first (this is the primary mutation in European populations)
  • C282Y homozygosity accounts for >90% of clinically characterized hereditary hemochromatosis 3
  • Testing for p.H63D can be performed in special situations but is not generally recommended to guide treatment alone 1

Important Clinical Pitfalls

Ferritin interpretation requires caution 2:

  • In the general population, iron overload is NOT the most common cause of elevated ferritin
  • Your patient has elevated liver enzymes, which could indicate necroinflammatory liver disease causing secondary ferritin elevation
  • However, the combination of elevated TS + elevated ferritin + liver enzyme abnormalities strongly suggests evaluating for hemochromatosis

When ferritin and TS are discordant 2:

  • Elevated ferritin with normal TS may indicate non-HFE-related iron overload or inflammatory conditions
  • Normal ferritin with TS <45% has 97% negative predictive value for excluding iron overload in patients <35 years

Additional Diagnostic Considerations

If genetic testing is negative or inconclusive 1:

  • 5-15% of patients with phenotypic hemochromatosis lack HFE mutations 4
  • Consider MRI for hepatic iron quantification
  • Liver biopsy with iron quantification may be indicated for non-HFE hemochromatosis

Do NOT measure hepcidin - this is not recommended for clinical diagnosis 1.

Prognostic Value of Ferritin

Beyond diagnosis, ferritin levels predict advanced fibrosis and cirrhosis risk in confirmed hemochromatosis 2. Higher ferritin levels (>1000 μg/L) correlate with increased risk of cirrhosis and hepatocellular carcinoma.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.